Jury Told Patent Typo Shouldn't Get Kite Off $752M Hook
Kite Pharma shouldn't be allowed to "exploit" a simple typo to "kill" a valuable cancer patent, a lawyer for Juno Therapeutics and Sloan Kettering told a California jury during closings Wednesday,...To view the full article, register now.
Already a subscriber? Click here to view full article